Inventor · disambiguated record
Li Chen
Also filed as: CHEN LI · Chen Li-Tzu
28 granted patents·7 pending applications·34 citations·filing 2007–2019
94Inventor score
Files withROCHE PALO ALTO LLC16CHEN LI8BIO CANCER TREAT INTERNATIONAL LIMITED3DILLON MICHAEL PATRICK3CHO PHARMA INC2
Top patents by PatentIndex Score
35 records- 0187US7595405B2Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2007·Granted Sep 29, 2009·7 cites·30 claims
- 0282US8048905B2Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2008·Granted Nov 1, 2011·4 cites·16 claims
- 0381US8841336B2Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2011·Granted Sep 23, 2014·4 cites·17 claims
- 0481US7786110B2Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2007·Granted Aug 31, 2010·5 cites·16 claims
- 0580US8119644B2Thiadiazole-substituted arylamides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2009·Granted Feb 21, 2012·3 cites·37 claims
- 0678US8193368B2Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsDILLON MICHAEL PATRICK·Filed 2009·Granted Jun 5, 2012·2 cites·34 claims
- 0776US9789169B2Methods and compositions for modulating the immune system with arginase IBIO-CANCER TREAT INT LTD·Filed 2015·Granted Oct 17, 2017·4 cites·39 claims
- 0872US10407673B2Methods for glycoprotein remodeling using endoglycosidase mutantsCHO PHARMA INC·Filed 2018·Granted Sep 10, 2019·1 cites·12 claims
- 0971US8501933B2Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2010·Granted Aug 6, 2013·1 cites·32 claims
- 1071US8440708B2Triazole-substituted arylamides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2011·Granted May 14, 2013·1 cites·28 claims
- 1170US9173861B2Thiadiazole-substituted arylamides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2012·Granted Nov 3, 2015·1 cites·20 claims
- 1266US9867875B2Methods and compositions for modulating the immune system with Arginase IBIO-CANCER TREAT INTERNATIONAL LIMITED·Filed 2016·Granted Jan 16, 2018·1 cites·30 claims
- 1364US8440673B2Pyrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2008·Granted May 14, 2013·0 cites·15 claims
- 1463US9512112B2Substituted pyridines as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2014·Granted Dec 6, 2016·0 cites·4 claims
- 1563US7989637B2Triazole-substituted arylamides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2008·Granted Aug 2, 2011·0 cites·10 claims
- 1661US10201525B2Tetrazole-substituted arylamides as PX2 and PX2/3 antagonistsROCHE PALO ALTO LLC·Filed 2017·Granted Feb 12, 2019·0 cites·10 claims
- 1761US8846945B2Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsDILLON MICHAEL PATRICK·Filed 2012·Granted Sep 30, 2014·0 cites·3 claims
- 1860US9512089B2Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2014·Granted Dec 6, 2016·0 cites·20 claims
- 1959US9593128B2Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsDILLON MICHAEL PATRICK·Filed 2014·Granted Mar 14, 2017·0 cites·26 claims
- 2059US2013296310A1Thiazole and oxazole-substituted arylamides as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2013·Application pending·0 cites
- 2158US9849136B2Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2017·Granted Dec 26, 2017·0 cites·1 claims
- 2258US8809402B2Oxazolone and pyrrolidinone-substituted biphenyls as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2011·Granted Aug 19, 2014·0 cites·15 claims
- 2358US2021368837A1Boehmeria nivea compositions and methods for taste modulationINT FLAVORS & FRAGRANCES INC·Filed 2019·Application pending·0 cites
- 2455US9617254B2Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2016·Granted Apr 11, 2017·0 cites·17 claims
- 2555US2013289025A1Pyrazole-substituted arylamides as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2013·Application pending·0 cites
- 2655US2017056398A1Substituted pyridines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2016·Application pending·0 cites
- 2755US2015065521A1Triazole-substituted arylamides as p2x3 and p2x2/3 modulatorsROCHE PALO ALTO LLC·Filed 2013·Application pending·0 cites
- 2854US8093275B2Oxazolone and pyrrolidinone-substituted pryidine amides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2010·Granted Jan 10, 2012·0 cites·17 claims
- 2953US10532086B2Methods and compositions for modulating the immune system with arginase IBIO CANCER TREAT INTERNATIONAL LIMITED·Filed 2017·Granted Jan 14, 2020·0 cites·18 claims
- 3053US9896439B2Pyrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2016·Granted Feb 20, 2018·0 cites·17 claims
- 3153US2020061165A1Methods and compositions for modulating the immune system with arginase iBIO CANCER TREAT INTERNATIONAL LIMITED·Filed 2019·Application pending·0 cites
- 3252US7858654B2Imidazole-substituted arylamides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2008·Granted Dec 28, 2010·0 cites·13 claims
- 3351US10000747B2Endoglycosidase mutants for glycoprotein remodeling and methods of using itCHO PHARMA INC·Filed 2017·Granted Jun 19, 2018·0 cites·4 claims
- 3448US12384855B2PCSK9 antagonistsKYMAB LTD·Filed 2019·Granted Aug 12, 2025·0 cites·9 claims
- 3548US2017081320A1Thiadiazole-substituted arylamides as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →